天然多糖类作为结直肠癌治疗中的药物输送系统
Zuzanna Senkowska1, Julia Wojtkowicz1, Katarzyna Owczarek2
1Oddział Nauk Biomedycznych Wydziału Lekarskiego, Uniwersytet Medyczny w Łodzi.
Postepy biochemii
|November 20, 2025
概括
天然多糖提供生物相容的药物递送系统 (DDS) 针对性结直肠癌治疗. 这些材料有效地提供化疗药物,减少全身毒性并改善抗癌治疗结果.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 天然多糖类具有独特的特性,如生物相容性和生物降解性,使它们成为先进药物递送系统 (DDS) 的理想选择.
- 针对胃肠道癌症,特别是结肠直肠癌的向治疗需要创新的输送方法来提高疗效并最大限度地减少副作用.
- 结直肠癌的瘤微环境为基于多糖的DDS的应用提供了具体的机会.
研究的目的:
- 探索天然多糖在开发选择性和受控的药物输送系统中的潜力.
- 对抗癌症应用的关键多糖的物理化学特性进行审查.
- 突出基于多糖的DDS在结直肠癌治疗中的临床相关性.
主要方法:
- 关于天然多糖的特性和应用的文献综述.
- 分析所选多糖的物理化学特征 (pectins, guar gum,纤维素,奇托桑,环极,酸盐).
- 在结直肠癌治疗中检查基于多糖的DDS的案例研究和临床应用.
主要成果:
- 精选的天然多糖化合物形成有效的囊,用于化疗.
- 这些基于多糖的DDS表现出活性剂的高选择性和受控释放.
- 多糖载体可以设计为直接向癌细胞,减少系统毒性.
结论:
- 天然多糖为设计用于结肠直肠癌的先进药物输送系统提供了很大的前景.
- 它们的固有特性有助于针对性地提供化疗药物,提高治疗效率.
- 基于多糖的DDS的进一步开发为创新的抗癌疗法具有重大潜力.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
435
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
435
01:20Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
553
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
553
01:21Drugs for Treatment of Constipation-Predominant IBS
682
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
682
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185
01:17Drugs for Treatment of Diarrhea-Predominant IBS
604
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
604
01:15Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K